XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | Note 12 — Earnings Per Share The computations of the numerator (earnings or loss) and denominator (shares) to derive the basic and diluted EPS amounts presented on the face of the accompanying consolidated statements of operations are as follows (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ | 2023 | ​ | 2022 |  | 2021
​ |  | Income |  | Shares |  | Income |  | Shares |  | Income |  | Shares
Basic and Diluted: |  | ​ |  |  |  |  | ​ |  |  |  | ​ | ​ |  |  |
Net loss attributable to common shareholders | ​ | $ | (10,838) | ​ | ​ |  | $ | (87,784) |  |  | ​ | $ | (61,538) |  |
Less: Accretion of redeemable noncontrolling interests | ​ |  | — | ​ | ​ |  | ​ | — |  |  | ​ | ​ | (241) |  |
Net loss available to common shareholders | ​ | $ | (10,838) | ​ | 150,917 | ​ | $ | (87,784) |  | 151,276 | ​ | $ | (61,779) |  | 150,056
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Loss per share | ​ | $ | (0.07) | ​ | ​ | ​ | $ | (0.58) | ​ | ​ | ​ | $ | (0.41) | ​ | ​
​ We had net losses for the years ended December 31, 2023, 2022 and 2021. Accordingly, our diluted EPS calculation for these periods excluded the dilutive effect of share-based awards because they were deemed to be anti-dilutive, meaning their inclusion would have reduced the reported net loss per share in the applicable periods. Shares that otherwise would have been included in the diluted per share calculations assuming we had earnings are as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ |  | 2023 |  | 2022 |  | 2021
Diluted shares (as reported) |  | 150,917 | ​ | 151,276 | ​ | 150,056
Share-based awards |  | 3,154 | ​ | 2,158 | ​ | 1,282
Total |  | 154,071 | ​ | 153,434 | ​ | 151,338
​ The following potentially dilutive shares related to the 2022 Notes, the 2023 Notes and the 2026 Notes were excluded from the diluted EPS calculation as they were anti-dilutive (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ | 2023 |  | 2022 |  | 2021
2022 Notes | ​ | — | ​ | 600 | ​ | 2,519
2023 Notes | ​ | 2,247 | ​ | 3,168 | ​ | 3,168
2026 Notes | ​ | 28,139 | ​ | 28,676 | ​ | 28,676
​ We have outstanding RSUs (Note 13) that can be settled in either cash or shares of our common stock or a combination thereof, which are not included in the computation of diluted EPS as cash settlement is assumed.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration